Skip to main content
Top
Published in: Behavioral and Brain Functions 1/2006

Open Access 01-12-2006 | Research

Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants

Authors: Gunjan M Modi, Pamela B Yang, Alan C Swann, Nachum Dafny

Published in: Behavioral and Brain Functions | Issue 1/2006

Login to get access

Abstract

Background

The recreational use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) among adolescents and young adults has become increasingly prevalent in recent years. While evidence suggests that the long-term consequences of MDMA use include neurodegeneration to serotonergic and, possibly, dopaminergic pathways, little is known about susceptibility, such as behavioral sensitization, to MDMA.

Methods

The objectives of this study were to examine the dose-response characteristics of acute and chronic MDMA administration in rats and to determine whether MDMA elicits behavioral sensitization and whether it cross-sensitizes with amphetamine and methylphenidate. Adult male Sprague-Dawley rats were randomly divided into three MDMA dosage groups (2.5 mg/kg, 5.0 mg/kg, and 10.0 mg/kg) and a saline control group (N = 9/group). All three MDMA groups were treated for six consecutive days, followed by a 5-day washout, and subsequently re-challenged with their respective doses of MDMA (day 13). Rats were then given an additional 25-day washout period, and re-challenged (day 38) with similar MDMA doses as before followed by either 0.6 mg/kg amphetamine or 2.5 mg/kg methylphenidate on the next day (day 39). Open-field locomotor activity was recorded using a computerized automated activity monitoring system.

Results

Acute injection of 2.5 mg/kg MDMA showed no significant difference in locomotor activity from rats given saline (control group), while animals receiving acute 5.0 mg/kg or 10.0 mg/kg MDMA showed significant increases in locomotor activity. Rats treated chronically with 5.0 mg/kg and 10.0 mg/kg MDMA doses exhibited an augmented response, i.e., behavioral sensitization, on experimental day 13 in at least one locomotor index. On experimental day 38, all three MDMA groups demonstrated sensitization to MDMA in at least one locomotor index. Amphetamine and methylphenidate administration to MDMA-sensitized animals did not elicit any significant change in locomotor activity compared to control animals.

Conclusion

MDMA sensitized to its own locomotor activating effects but did not elicit any cross-sensitization with amphetamine or methylphenidate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Strote J, Lee JE, Wechsler H: Increasing MDMA use among college students: results of a national survey. J Adolesc Health. 2002, 30 (1): 64-72. 10.1016/S1054-139X(01)00315-9.PubMedCrossRef Strote J, Lee JE, Wechsler H: Increasing MDMA use among college students: results of a national survey. J Adolesc Health. 2002, 30 (1): 64-72. 10.1016/S1054-139X(01)00315-9.PubMedCrossRef
2.
go back to reference Johnston LD, O'Malley PM, Bachman JG: Monitoring the Future national results on adolescent drug use: Overview of key findings, 2002. National Institutes on Drug Abuse. 2003, NIH Publication No. 03-5374: Johnston LD, O'Malley PM, Bachman JG: Monitoring the Future national results on adolescent drug use: Overview of key findings, 2002. National Institutes on Drug Abuse. 2003, NIH Publication No. 03-5374:
3.
4.
go back to reference Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV: 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci. 2001, 21 (9): 3228-3235.PubMed Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV: 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci. 2001, 21 (9): 3228-3235.PubMed
5.
go back to reference Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV: Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res. 2003, 968 (1): 89-101. 10.1016/S0006-8993(02)04278-6.PubMedCrossRef Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV: Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res. 2003, 968 (1): 89-101. 10.1016/S0006-8993(02)04278-6.PubMedCrossRef
6.
go back to reference Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS: Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol. 2001, 433 (1): 91-99. 10.1016/S0014-2999(01)01512-6.PubMedCrossRef Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS: Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol. 2001, 433 (1): 91-99. 10.1016/S0014-2999(01)01512-6.PubMedCrossRef
7.
go back to reference Sprague JE, Preston AS, Leifheit M, Woodside B: Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav. 2003, 79 (2): 281-287. 10.1016/S0031-9384(03)00092-1.PubMedCrossRef Sprague JE, Preston AS, Leifheit M, Woodside B: Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav. 2003, 79 (2): 281-287. 10.1016/S0031-9384(03)00092-1.PubMedCrossRef
8.
go back to reference Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP: Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl). 1999, 144 (1): 67-76. 10.1007/s002130050978.CrossRef Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP: Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl). 1999, 144 (1): 67-76. 10.1007/s002130050978.CrossRef
9.
go back to reference Fone KC, Beckett SR, Topham IA, Swettenham J, Ball M, Maddocks L: Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology (Berl). 2002, 159 (4): 437-444. 10.1007/s00213-001-0931-z.CrossRef Fone KC, Beckett SR, Topham IA, Swettenham J, Ball M, Maddocks L: Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology (Berl). 2002, 159 (4): 437-444. 10.1007/s00213-001-0931-z.CrossRef
10.
go back to reference Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS: Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol. 2002, 446 (1-3): 89-96. 10.1016/S0014-2999(02)01820-4.PubMedCrossRef Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS: Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol. 2002, 446 (1-3): 89-96. 10.1016/S0014-2999(02)01820-4.PubMedCrossRef
11.
go back to reference Maldonado E, Navarro JF: MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacol Res. 2001, 44 (1): 27-31. 10.1006/phrs.2001.0824.PubMedCrossRef Maldonado E, Navarro JF: MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacol Res. 2001, 44 (1): 27-31. 10.1006/phrs.2001.0824.PubMedCrossRef
12.
go back to reference Matuszewich L, Filon ME, Finn DA, Yamamoto BK: Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine. Neuroscience. 2002, 110 (1): 41-48. 10.1016/S0306-4522(01)00539-5.PubMedCrossRef Matuszewich L, Filon ME, Finn DA, Yamamoto BK: Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine. Neuroscience. 2002, 110 (1): 41-48. 10.1016/S0306-4522(01)00539-5.PubMedCrossRef
13.
14.
go back to reference Spanos LJ, Yamamoto BK: Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav. 1989, 32 (4): 835-840. 10.1016/0091-3057(89)90044-0.PubMedCrossRef Spanos LJ, Yamamoto BK: Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav. 1989, 32 (4): 835-840. 10.1016/0091-3057(89)90044-0.PubMedCrossRef
15.
go back to reference Gold LH, Koob GF: MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl). 1989, 99 (3): 352-356. 10.1007/BF00445556.CrossRef Gold LH, Koob GF: MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl). 1989, 99 (3): 352-356. 10.1007/BF00445556.CrossRef
16.
go back to reference McNamara MG, Kelly JP, Leonard BE: Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav. 1995, 52 (3): 479-484. 10.1016/0091-3057(95)00206-C.PubMedCrossRef McNamara MG, Kelly JP, Leonard BE: Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav. 1995, 52 (3): 479-484. 10.1016/0091-3057(95)00206-C.PubMedCrossRef
17.
go back to reference Dar KJ, McBrien ME: MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med. 1996, 22 (9): 995-996.PubMedCrossRef Dar KJ, McBrien ME: MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med. 1996, 22 (9): 995-996.PubMedCrossRef
18.
go back to reference Dafters RI: Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav. 1995, 58 (5): 877-882. 10.1016/0031-9384(95)00136-7.PubMedCrossRef Dafters RI: Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav. 1995, 58 (5): 877-882. 10.1016/0031-9384(95)00136-7.PubMedCrossRef
19.
go back to reference Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL: The health effects of ecstasy: a literature review. Drug Alcohol Rev. 2002, 21 (1): 53-63. 10.1080/09595230220119363.PubMedCrossRef Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL: The health effects of ecstasy: a literature review. Drug Alcohol Rev. 2002, 21 (1): 53-63. 10.1080/09595230220119363.PubMedCrossRef
20.
go back to reference Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB: Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav. 1991, 38 (2): 339-344. 10.1016/0091-3057(91)90288-D.PubMedCrossRef Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB: Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav. 1991, 38 (2): 339-344. 10.1016/0091-3057(91)90288-D.PubMedCrossRef
21.
22.
go back to reference Gudelsky GA, Nash JF: Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J Neurochem. 1996, 66 (1): 243-249.PubMedCrossRef Gudelsky GA, Nash JF: Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J Neurochem. 1996, 66 (1): 243-249.PubMedCrossRef
23.
go back to reference Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE: Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav. 1996, 53 (1): 99-105. 10.1016/0091-3057(95)00205-7.PubMedCrossRef Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE: Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav. 1996, 53 (1): 99-105. 10.1016/0091-3057(95)00205-7.PubMedCrossRef
24.
go back to reference Shankaran M, Yamamoto BK, Gudelsky GA: Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur J Pharmacol. 1999, 385 (2-3): 103-110. 10.1016/S0014-2999(99)00728-1.PubMedCrossRef Shankaran M, Yamamoto BK, Gudelsky GA: Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur J Pharmacol. 1999, 385 (2-3): 103-110. 10.1016/S0014-2999(99)00728-1.PubMedCrossRef
25.
go back to reference Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993, 18 (3): 247-291. 10.1016/0165-0173(93)90013-P.PubMedCrossRef Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993, 18 (3): 247-291. 10.1016/0165-0173(93)90013-P.PubMedCrossRef
26.
go back to reference Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986, 396 (2): 157-198. 10.1016/S0006-8993(86)80193-7.PubMedCrossRef Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986, 396 (2): 157-198. 10.1016/S0006-8993(86)80193-7.PubMedCrossRef
27.
go back to reference Kalivas PW, Duffy P, White SR: MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology. 1998, 18 (6): 469-479. 10.1016/S0893-133X(97)00195-4.PubMedCrossRef Kalivas PW, Duffy P, White SR: MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology. 1998, 18 (6): 469-479. 10.1016/S0893-133X(97)00195-4.PubMedCrossRef
28.
go back to reference Gaytan O, Swann AC, Dafny N: Effects of amphetamine at the beginning of the light cycle on multiple indices of motor activity in the rat. Eur J Pharmacol. 1996, 300 (1-2): 1-8. 10.1016/0014-2999(95)00843-8.PubMedCrossRef Gaytan O, Swann AC, Dafny N: Effects of amphetamine at the beginning of the light cycle on multiple indices of motor activity in the rat. Eur J Pharmacol. 1996, 300 (1-2): 1-8. 10.1016/0014-2999(95)00843-8.PubMedCrossRef
29.
go back to reference Gaytan O, al-Rahim S, Swann A, Dafny N: Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 1997, 61 (8): PL101-7. 10.1016/S0024-3205(97)00598-5.PubMedCrossRef Gaytan O, al-Rahim S, Swann A, Dafny N: Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 1997, 61 (8): PL101-7. 10.1016/S0024-3205(97)00598-5.PubMedCrossRef
30.
go back to reference Yang P, Singhal N, Modi G, Swann A, Dafny N: Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur J Pharmacol. 2001, 426 (1-2): 65-72. 10.1016/S0014-2999(01)01213-4.PubMedCrossRef Yang P, Singhal N, Modi G, Swann A, Dafny N: Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur J Pharmacol. 2001, 426 (1-2): 65-72. 10.1016/S0014-2999(01)01213-4.PubMedCrossRef
31.
go back to reference Nagilla R, Newland MC, Snyder J, Bronson ME: Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats. Eur J Pharmacol. 1998, 358 (1): 1-8. 10.1016/S0014-2999(98)00569-X.PubMedCrossRef Nagilla R, Newland MC, Snyder J, Bronson ME: Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats. Eur J Pharmacol. 1998, 358 (1): 1-8. 10.1016/S0014-2999(98)00569-X.PubMedCrossRef
32.
go back to reference Callaway CW, Geyer MA: Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther. 1992, 263 (1): 318-326.PubMed Callaway CW, Geyer MA: Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther. 1992, 263 (1): 318-326.PubMed
33.
go back to reference Bonate PL, Swann A, Silverman PB: Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci. 1997, 60 (1): PL1-7. 10.1016/S0024-3205(96)00591-7.PubMed Bonate PL, Swann A, Silverman PB: Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci. 1997, 60 (1): PL1-7. 10.1016/S0024-3205(96)00591-7.PubMed
34.
go back to reference Yang PB, Swann AC, Dafny N: Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci. 2003, 73 (22): 2899-2911. 10.1016/S0024-3205(03)00673-8.PubMedCrossRef Yang PB, Swann AC, Dafny N: Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci. 2003, 73 (22): 2899-2911. 10.1016/S0024-3205(03)00673-8.PubMedCrossRef
35.
go back to reference Brandon CL, Marinelli M, Baker LK, White FJ: Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 2001, 25 (5): 651-661. 10.1016/S0893-133X(01)00281-0.PubMedCrossRef Brandon CL, Marinelli M, Baker LK, White FJ: Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 2001, 25 (5): 651-661. 10.1016/S0893-133X(01)00281-0.PubMedCrossRef
36.
go back to reference Itzhak Y, Ali SF, Achat CN, Anderson KL: Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology (Berl). 2003, 166 (3): 241-248. Itzhak Y, Ali SF, Achat CN, Anderson KL: Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology (Berl). 2003, 166 (3): 241-248.
37.
go back to reference Achat-Mendes C, Anderson KL, Itzhak Y: Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology. 2003, 45 (1): 106-115. 10.1016/S0028-3908(03)00135-7.PubMedCrossRef Achat-Mendes C, Anderson KL, Itzhak Y: Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology. 2003, 45 (1): 106-115. 10.1016/S0028-3908(03)00135-7.PubMedCrossRef
38.
go back to reference Segal DS, Geyer MA, Schuckit MA: Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol. 1981, 5: 95-129.PubMed Segal DS, Geyer MA, Schuckit MA: Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol. 1981, 5: 95-129.PubMed
39.
go back to reference Fletcher PJ, Robinson SR, Slippoy DL: Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology. 2001, 25 (2): 195-203. 10.1016/S0893-133X(01)00222-6.PubMedCrossRef Fletcher PJ, Robinson SR, Slippoy DL: Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology. 2001, 25 (2): 195-203. 10.1016/S0893-133X(01)00222-6.PubMedCrossRef
40.
go back to reference Bjork JM, Gaytan O, Patt N, Swann AC, Dafny N: Behavioral tolerance to and withdrawal from multiple fluoxetine administration. Int J Neurosci. 1998, 93 (3-4): 163-179.PubMedCrossRef Bjork JM, Gaytan O, Patt N, Swann AC, Dafny N: Behavioral tolerance to and withdrawal from multiple fluoxetine administration. Int J Neurosci. 1998, 93 (3-4): 163-179.PubMedCrossRef
41.
go back to reference Cole JC, Sumnall HR: The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev. 2003, 27 (3): 199-217. 10.1016/S0149-7634(03)00031-9.PubMedCrossRef Cole JC, Sumnall HR: The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev. 2003, 27 (3): 199-217. 10.1016/S0149-7634(03)00031-9.PubMedCrossRef
42.
go back to reference Ratzenboeck E, Saria A, Kriechbaum N, Zernig G: Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology. 2001, 62 (3): 138-144. 10.1159/000056086.PubMedCrossRef Ratzenboeck E, Saria A, Kriechbaum N, Zernig G: Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology. 2001, 62 (3): 138-144. 10.1159/000056086.PubMedCrossRef
43.
go back to reference Schenk S, Gittings D, Johnstone M, Daniela E: Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl). 2003, 169 (1): 21-27. 10.1007/s00213-003-1407-0.CrossRef Schenk S, Gittings D, Johnstone M, Daniela E: Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl). 2003, 169 (1): 21-27. 10.1007/s00213-003-1407-0.CrossRef
44.
go back to reference Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS: Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol. 2003, 482 (1-3): 339-341. 10.1016/j.ejphar.2003.09.060.PubMedCrossRef Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS: Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol. 2003, 482 (1-3): 339-341. 10.1016/j.ejphar.2003.09.060.PubMedCrossRef
45.
go back to reference Fletcher PJ, Korth KM, Robinson SR, Baker GB: Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl). 2002, 162 (3): 282-291. 10.1007/s00213-002-1104-4.CrossRef Fletcher PJ, Korth KM, Robinson SR, Baker GB: Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl). 2002, 162 (3): 282-291. 10.1007/s00213-002-1104-4.CrossRef
46.
go back to reference Anderson KL, Itzhak Y: Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice. Nitric Oxide. 2003, 9 (1): 24-32. 10.1016/S1089-8603(03)00046-6.PubMedCrossRef Anderson KL, Itzhak Y: Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice. Nitric Oxide. 2003, 9 (1): 24-32. 10.1016/S1089-8603(03)00046-6.PubMedCrossRef
47.
go back to reference McCreary AC, Bankson MG, Cunningham KA: Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J Pharmacol Exp Ther. 1999, 290 (3): 965-973.PubMed McCreary AC, Bankson MG, Cunningham KA: Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J Pharmacol Exp Ther. 1999, 290 (3): 965-973.PubMed
48.
go back to reference Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003, 55 (3): 463-508. 10.1124/pr.55.3.3.PubMedCrossRef Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003, 55 (3): 463-508. 10.1124/pr.55.3.3.PubMedCrossRef
49.
go back to reference Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997, 25 (2): 192-216. 10.1016/S0165-0173(97)00021-0.PubMedCrossRef Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997, 25 (2): 192-216. 10.1016/S0165-0173(97)00021-0.PubMedCrossRef
50.
go back to reference Kalivas PW, Duffy P: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 1993, 13 (1): 266-275.PubMed Kalivas PW, Duffy P: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 1993, 13 (1): 266-275.PubMed
51.
go back to reference Callaway CW, Wing LL, Geyer MA: Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther. 1990, 254 (2): 456-464.PubMed Callaway CW, Wing LL, Geyer MA: Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther. 1990, 254 (2): 456-464.PubMed
52.
go back to reference Gold LH, Koob GF, Geyer MA: Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther. 1988, 247 (2): 547-555.PubMed Gold LH, Koob GF, Geyer MA: Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther. 1988, 247 (2): 547-555.PubMed
53.
go back to reference Gough B, Ali SF, Slikker WJ, Holson RR: Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav. 1991, 39 (3): 619-623. 10.1016/0091-3057(91)90137-Q.PubMedCrossRef Gough B, Ali SF, Slikker WJ, Holson RR: Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav. 1991, 39 (3): 619-623. 10.1016/0091-3057(91)90137-Q.PubMedCrossRef
54.
go back to reference Yamamoto BK, Spanos LJ: The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol. 1988, 148 (2): 195-203. 10.1016/0014-2999(88)90564-X.PubMedCrossRef Yamamoto BK, Spanos LJ: The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol. 1988, 148 (2): 195-203. 10.1016/0014-2999(88)90564-X.PubMedCrossRef
55.
go back to reference Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR: A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br J Pharmacol. 2001, 134 (8): 1711-1723. 10.1038/sj.bjp.0704435.PubMedCentralPubMedCrossRef Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR: A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br J Pharmacol. 2001, 134 (8): 1711-1723. 10.1038/sj.bjp.0704435.PubMedCentralPubMedCrossRef
56.
go back to reference O'Shea E, Esteban B, Camarero J, Green AR, Colado MI: Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology. 2001, 40 (1): 65-74. 10.1016/S0028-3908(00)00106-4.PubMedCrossRef O'Shea E, Esteban B, Camarero J, Green AR, Colado MI: Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology. 2001, 40 (1): 65-74. 10.1016/S0028-3908(00)00106-4.PubMedCrossRef
57.
go back to reference Koch S, Galloway MP: MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm. 1997, 104 (2-3): 135-146. 10.1007/BF01273176.PubMedCrossRef Koch S, Galloway MP: MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm. 1997, 104 (2-3): 135-146. 10.1007/BF01273176.PubMedCrossRef
58.
go back to reference Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996, 379 (6566): 606-612. 10.1038/379606a0.PubMedCrossRef Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996, 379 (6566): 606-612. 10.1038/379606a0.PubMedCrossRef
59.
go back to reference Karler R, Calder LD, Thai LH, Bedingfield JB: The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res. 1995, 671 (1): 100-104. 10.1016/0006-8993(94)01334-E.PubMedCrossRef Karler R, Calder LD, Thai LH, Bedingfield JB: The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res. 1995, 671 (1): 100-104. 10.1016/0006-8993(94)01334-E.PubMedCrossRef
60.
go back to reference Pettit HO, Pan HT, Parsons LH, Justice JBJ: Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem. 1990, 55 (3): 798-804.PubMedCrossRef Pettit HO, Pan HT, Parsons LH, Justice JBJ: Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem. 1990, 55 (3): 798-804.PubMedCrossRef
61.
go back to reference Paulson PE, Robinson TE: Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 1995, 19 (1): 56-65. 10.1002/syn.890190108.PubMedCentralPubMedCrossRef Paulson PE, Robinson TE: Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 1995, 19 (1): 56-65. 10.1002/syn.890190108.PubMedCentralPubMedCrossRef
62.
go back to reference Paulson PE, Camp DM, Robinson TE: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl). 1991, 103 (4): 480-492. 10.1007/BF02244248.CrossRef Paulson PE, Camp DM, Robinson TE: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl). 1991, 103 (4): 480-492. 10.1007/BF02244248.CrossRef
63.
go back to reference Wise RA, Leeb K: Psychomotor-stimulant sensitization: a unitary phenomenon?. Behav Pharmacol. 1993, 4 (4): 339-349.PubMedCrossRef Wise RA, Leeb K: Psychomotor-stimulant sensitization: a unitary phenomenon?. Behav Pharmacol. 1993, 4 (4): 339-349.PubMedCrossRef
64.
go back to reference Cole JC, Sumnall HR, O'Shea E, Marsden CA: Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl). 2003, 166 (4): 383-390. Cole JC, Sumnall HR, O'Shea E, Marsden CA: Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl). 2003, 166 (4): 383-390.
65.
go back to reference Horan B, Gardner EL, Ashby CRJ: Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA). Synapse. 2000, 35 (2): 160-162. 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.0.CO;2-O.PubMedCrossRef Horan B, Gardner EL, Ashby CRJ: Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA). Synapse. 2000, 35 (2): 160-162. 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.0.CO;2-O.PubMedCrossRef
66.
go back to reference Morgan AE, Horan B, Dewey SL, Ashby CRJ: Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur J Pharmacol. 1997, 331 (1): R1-3. 10.1016/S0014-2999(97)01035-2.PubMedCrossRef Morgan AE, Horan B, Dewey SL, Ashby CRJ: Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur J Pharmacol. 1997, 331 (1): R1-3. 10.1016/S0014-2999(97)01035-2.PubMedCrossRef
67.
go back to reference Yamamoto BK, Nash JF, Gudelsky GA: Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther. 1995, 273 (3): 1063-1070.PubMed Yamamoto BK, Nash JF, Gudelsky GA: Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther. 1995, 273 (3): 1063-1070.PubMed
68.
go back to reference Gaytan O, Yang P, Swann A, Dafny N: Diurnal differences in sensitization to methylphenidate. Brain Res. 2000, 864 (1): 24-39. 10.1016/S0006-8993(00)02117-X.PubMedCrossRef Gaytan O, Yang P, Swann A, Dafny N: Diurnal differences in sensitization to methylphenidate. Brain Res. 2000, 864 (1): 24-39. 10.1016/S0006-8993(00)02117-X.PubMedCrossRef
69.
go back to reference Gaytan O, Swann A, Dafny N: Time-dependent differences in the rat's motor response to amphetamine. Pharmacol Biochem Behav. 1998, 59 (2): 459-467. 10.1016/S0091-3057(97)00438-3.PubMedCrossRef Gaytan O, Swann A, Dafny N: Time-dependent differences in the rat's motor response to amphetamine. Pharmacol Biochem Behav. 1998, 59 (2): 459-467. 10.1016/S0091-3057(97)00438-3.PubMedCrossRef
Metadata
Title
Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants
Authors
Gunjan M Modi
Pamela B Yang
Alan C Swann
Nachum Dafny
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Behavioral and Brain Functions / Issue 1/2006
Electronic ISSN: 1744-9081
DOI
https://doi.org/10.1186/1744-9081-2-1

Other articles of this Issue 1/2006

Behavioral and Brain Functions 1/2006 Go to the issue